Postexposure prophylaxis of varicella in family contact by oral acyclovir

Y. Asano, T. Yoshikawa, S. Suga, I. Kobayashi, T. Nakashima, T. Yazaki, T. Ozaki, A. Yamada, J. Imanishi

Research output: Contribution to journalArticle

106 Citations (Scopus)

Abstract

Objective. To determine whether varicella can be prevented by administration of oral acyclovir (ACV) during the incubation period of the disease. Subjects and methods. ACV (40 or 80 mg/kg daily in four divided doses) was given orally to 25 exposed infants and children for 7 days, starting 7 to 9 days after exposure from the index case in their families. Their clinical features were compared with those of 25 age-matched control subjects who had been exposed in their families but did not receive ACV. A fluorescent antibody to membrane antigen assay was used for determination of the antibody to varicella-zoster virus, and a nested polymerase chain reaction method was used for detection of viremia. Results. Among the 25 who received ACV, 4 (16%) developed the disease and 1 (4%) had a fever. On the other hand, all of 25 control subjects developed the disease and 17 (68%) had a fever. The incidence of fever and the severity of skin rashes were significantly lower (P < .01) in the subjects who received oral ACV than in the control group. Seroconversion was observed in 84% of subjects who received ACV. In some cases, varicella-zoster virus DNA was detected by polymerase chain reaction amplification in peripheral blood mononuclear cells from blood drawn approximately 14 days after exposure. Conclusions. Varicella can be prevented or modified by administration of oral ACV late in the incubation period.

Original languageEnglish
Pages (from-to)219-222
Number of pages4
JournalPediatrics
Volume92
Issue number2 I
Publication statusPublished - 01-01-1993

Fingerprint

Acyclovir
Chickenpox
Human Herpesvirus 3
Fever
Oral Administration
Polymerase Chain Reaction
Antibodies
Viremia
Exanthema
Blood Cells
Antigens
Control Groups
Membranes
DNA
Incidence

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health

Cite this

Asano, Y., Yoshikawa, T., Suga, S., Kobayashi, I., Nakashima, T., Yazaki, T., ... Imanishi, J. (1993). Postexposure prophylaxis of varicella in family contact by oral acyclovir. Pediatrics, 92(2 I), 219-222.
Asano, Y. ; Yoshikawa, T. ; Suga, S. ; Kobayashi, I. ; Nakashima, T. ; Yazaki, T. ; Ozaki, T. ; Yamada, A. ; Imanishi, J. / Postexposure prophylaxis of varicella in family contact by oral acyclovir. In: Pediatrics. 1993 ; Vol. 92, No. 2 I. pp. 219-222.
@article{5c2a3b48076c488c9cb6d32dcac3b3e9,
title = "Postexposure prophylaxis of varicella in family contact by oral acyclovir",
abstract = "Objective. To determine whether varicella can be prevented by administration of oral acyclovir (ACV) during the incubation period of the disease. Subjects and methods. ACV (40 or 80 mg/kg daily in four divided doses) was given orally to 25 exposed infants and children for 7 days, starting 7 to 9 days after exposure from the index case in their families. Their clinical features were compared with those of 25 age-matched control subjects who had been exposed in their families but did not receive ACV. A fluorescent antibody to membrane antigen assay was used for determination of the antibody to varicella-zoster virus, and a nested polymerase chain reaction method was used for detection of viremia. Results. Among the 25 who received ACV, 4 (16{\%}) developed the disease and 1 (4{\%}) had a fever. On the other hand, all of 25 control subjects developed the disease and 17 (68{\%}) had a fever. The incidence of fever and the severity of skin rashes were significantly lower (P < .01) in the subjects who received oral ACV than in the control group. Seroconversion was observed in 84{\%} of subjects who received ACV. In some cases, varicella-zoster virus DNA was detected by polymerase chain reaction amplification in peripheral blood mononuclear cells from blood drawn approximately 14 days after exposure. Conclusions. Varicella can be prevented or modified by administration of oral ACV late in the incubation period.",
author = "Y. Asano and T. Yoshikawa and S. Suga and I. Kobayashi and T. Nakashima and T. Yazaki and T. Ozaki and A. Yamada and J. Imanishi",
year = "1993",
month = "1",
day = "1",
language = "English",
volume = "92",
pages = "219--222",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "2 I",

}

Asano, Y, Yoshikawa, T, Suga, S, Kobayashi, I, Nakashima, T, Yazaki, T, Ozaki, T, Yamada, A & Imanishi, J 1993, 'Postexposure prophylaxis of varicella in family contact by oral acyclovir', Pediatrics, vol. 92, no. 2 I, pp. 219-222.

Postexposure prophylaxis of varicella in family contact by oral acyclovir. / Asano, Y.; Yoshikawa, T.; Suga, S.; Kobayashi, I.; Nakashima, T.; Yazaki, T.; Ozaki, T.; Yamada, A.; Imanishi, J.

In: Pediatrics, Vol. 92, No. 2 I, 01.01.1993, p. 219-222.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Postexposure prophylaxis of varicella in family contact by oral acyclovir

AU - Asano, Y.

AU - Yoshikawa, T.

AU - Suga, S.

AU - Kobayashi, I.

AU - Nakashima, T.

AU - Yazaki, T.

AU - Ozaki, T.

AU - Yamada, A.

AU - Imanishi, J.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Objective. To determine whether varicella can be prevented by administration of oral acyclovir (ACV) during the incubation period of the disease. Subjects and methods. ACV (40 or 80 mg/kg daily in four divided doses) was given orally to 25 exposed infants and children for 7 days, starting 7 to 9 days after exposure from the index case in their families. Their clinical features were compared with those of 25 age-matched control subjects who had been exposed in their families but did not receive ACV. A fluorescent antibody to membrane antigen assay was used for determination of the antibody to varicella-zoster virus, and a nested polymerase chain reaction method was used for detection of viremia. Results. Among the 25 who received ACV, 4 (16%) developed the disease and 1 (4%) had a fever. On the other hand, all of 25 control subjects developed the disease and 17 (68%) had a fever. The incidence of fever and the severity of skin rashes were significantly lower (P < .01) in the subjects who received oral ACV than in the control group. Seroconversion was observed in 84% of subjects who received ACV. In some cases, varicella-zoster virus DNA was detected by polymerase chain reaction amplification in peripheral blood mononuclear cells from blood drawn approximately 14 days after exposure. Conclusions. Varicella can be prevented or modified by administration of oral ACV late in the incubation period.

AB - Objective. To determine whether varicella can be prevented by administration of oral acyclovir (ACV) during the incubation period of the disease. Subjects and methods. ACV (40 or 80 mg/kg daily in four divided doses) was given orally to 25 exposed infants and children for 7 days, starting 7 to 9 days after exposure from the index case in their families. Their clinical features were compared with those of 25 age-matched control subjects who had been exposed in their families but did not receive ACV. A fluorescent antibody to membrane antigen assay was used for determination of the antibody to varicella-zoster virus, and a nested polymerase chain reaction method was used for detection of viremia. Results. Among the 25 who received ACV, 4 (16%) developed the disease and 1 (4%) had a fever. On the other hand, all of 25 control subjects developed the disease and 17 (68%) had a fever. The incidence of fever and the severity of skin rashes were significantly lower (P < .01) in the subjects who received oral ACV than in the control group. Seroconversion was observed in 84% of subjects who received ACV. In some cases, varicella-zoster virus DNA was detected by polymerase chain reaction amplification in peripheral blood mononuclear cells from blood drawn approximately 14 days after exposure. Conclusions. Varicella can be prevented or modified by administration of oral ACV late in the incubation period.

UR - http://www.scopus.com/inward/record.url?scp=0027280056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027280056&partnerID=8YFLogxK

M3 - Article

C2 - 8393173

AN - SCOPUS:0027280056

VL - 92

SP - 219

EP - 222

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 2 I

ER -

Asano Y, Yoshikawa T, Suga S, Kobayashi I, Nakashima T, Yazaki T et al. Postexposure prophylaxis of varicella in family contact by oral acyclovir. Pediatrics. 1993 Jan 1;92(2 I):219-222.